«The totality of evidence clearly indicates that the more widespread and appropriate utilization of statins,
as adjuncts, not alternatives to therapeutic lifestyle changes, will yield net benefits in the treatment and
primary prevention of heart attacks and strokes, including among high,
medium and low risk patients unwilling or unable to
adopt therapeutic lifestyle changes,» said Hennekens.